Caring for the renal failure patient: optimizing iron therapy.

Vaughn Wesley Folkert, Asuncion M. Javier, Neeta B. O'Mara

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The effectiveness of anemia management in patients with end stage renal disease (ESRD) has increased over the past 4 years. However, approximately 26% of treated patients still do not meet the minimum hemoglobin (Hgb) value of 11 g/dl that is recommended by the K/DOQI Clinical Practice Guidelines (National Kidney Foundation [NKF], 2001). One of the main obstacles to good patient outcome may be iron deficiency, which is common in both the predialysis and dialysis period. Since iron is needed for Hgb synthesis, iron depletion exacerbated anemia and reduces the response to recombinant erythropoietin (rEPO) therapy. Health care providers can significantly improve patient outcome by addressing iron deficiency more rigorously. A good starting point is the establishment of an iron deficiency management protocol that includes early evaluation of iron status and aggressive iron therapy. Iron therapy, in turn, can be optimized by administering safe and effective iron supplements and by implementing maintenance iron regimens to prevent the recurrence of iron deficiency. By making these simple improvements to their treatment approach, clinicians can enhance the effectiveness of anemia management in patients with ESRD.

Original languageEnglish (US)
JournalNephrology nursing journal : journal of the American Nephrology Nurses' Association
Volume29
Issue number6
StatePublished - 2002

Fingerprint

Renal Insufficiency
Iron
Therapeutics
Anemia
Chronic Kidney Failure
Hemoglobins
Erythropoietin
Practice Guidelines
Health Personnel
Dialysis
Maintenance
Kidney
Recurrence

Cite this

Caring for the renal failure patient : optimizing iron therapy. / Folkert, Vaughn Wesley; Javier, Asuncion M.; O'Mara, Neeta B.

In: Nephrology nursing journal : journal of the American Nephrology Nurses' Association, Vol. 29, No. 6, 2002.

Research output: Contribution to journalArticle

@article{a0d543215506402d9bc275671a52a1a0,
title = "Caring for the renal failure patient: optimizing iron therapy.",
abstract = "The effectiveness of anemia management in patients with end stage renal disease (ESRD) has increased over the past 4 years. However, approximately 26{\%} of treated patients still do not meet the minimum hemoglobin (Hgb) value of 11 g/dl that is recommended by the K/DOQI Clinical Practice Guidelines (National Kidney Foundation [NKF], 2001). One of the main obstacles to good patient outcome may be iron deficiency, which is common in both the predialysis and dialysis period. Since iron is needed for Hgb synthesis, iron depletion exacerbated anemia and reduces the response to recombinant erythropoietin (rEPO) therapy. Health care providers can significantly improve patient outcome by addressing iron deficiency more rigorously. A good starting point is the establishment of an iron deficiency management protocol that includes early evaluation of iron status and aggressive iron therapy. Iron therapy, in turn, can be optimized by administering safe and effective iron supplements and by implementing maintenance iron regimens to prevent the recurrence of iron deficiency. By making these simple improvements to their treatment approach, clinicians can enhance the effectiveness of anemia management in patients with ESRD.",
author = "Folkert, {Vaughn Wesley} and Javier, {Asuncion M.} and O'Mara, {Neeta B.}",
year = "2002",
language = "English (US)",
volume = "29",
journal = "Nephrology Nursing Journal",
issn = "1526-744X",
publisher = "Jannetti Publications, Inc.",
number = "6",

}

TY - JOUR

T1 - Caring for the renal failure patient

T2 - optimizing iron therapy.

AU - Folkert, Vaughn Wesley

AU - Javier, Asuncion M.

AU - O'Mara, Neeta B.

PY - 2002

Y1 - 2002

N2 - The effectiveness of anemia management in patients with end stage renal disease (ESRD) has increased over the past 4 years. However, approximately 26% of treated patients still do not meet the minimum hemoglobin (Hgb) value of 11 g/dl that is recommended by the K/DOQI Clinical Practice Guidelines (National Kidney Foundation [NKF], 2001). One of the main obstacles to good patient outcome may be iron deficiency, which is common in both the predialysis and dialysis period. Since iron is needed for Hgb synthesis, iron depletion exacerbated anemia and reduces the response to recombinant erythropoietin (rEPO) therapy. Health care providers can significantly improve patient outcome by addressing iron deficiency more rigorously. A good starting point is the establishment of an iron deficiency management protocol that includes early evaluation of iron status and aggressive iron therapy. Iron therapy, in turn, can be optimized by administering safe and effective iron supplements and by implementing maintenance iron regimens to prevent the recurrence of iron deficiency. By making these simple improvements to their treatment approach, clinicians can enhance the effectiveness of anemia management in patients with ESRD.

AB - The effectiveness of anemia management in patients with end stage renal disease (ESRD) has increased over the past 4 years. However, approximately 26% of treated patients still do not meet the minimum hemoglobin (Hgb) value of 11 g/dl that is recommended by the K/DOQI Clinical Practice Guidelines (National Kidney Foundation [NKF], 2001). One of the main obstacles to good patient outcome may be iron deficiency, which is common in both the predialysis and dialysis period. Since iron is needed for Hgb synthesis, iron depletion exacerbated anemia and reduces the response to recombinant erythropoietin (rEPO) therapy. Health care providers can significantly improve patient outcome by addressing iron deficiency more rigorously. A good starting point is the establishment of an iron deficiency management protocol that includes early evaluation of iron status and aggressive iron therapy. Iron therapy, in turn, can be optimized by administering safe and effective iron supplements and by implementing maintenance iron regimens to prevent the recurrence of iron deficiency. By making these simple improvements to their treatment approach, clinicians can enhance the effectiveness of anemia management in patients with ESRD.

UR - http://www.scopus.com/inward/record.url?scp=0036981595&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036981595&partnerID=8YFLogxK

M3 - Article

C2 - 12596608

AN - SCOPUS:0036981595

VL - 29

JO - Nephrology Nursing Journal

JF - Nephrology Nursing Journal

SN - 1526-744X

IS - 6

ER -